EP3773548
IN VITRO AND XENOGRAFT ANTI-TUMOR ACTIVITY OF A HALOGENATED-XANTHENE AGAINST REFRACTORY PEDIATRIC SOLID TUMORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.5.2019EP published:
9.8.2023EP application number:
19804326.7
EPO information:
European Patent Register
Max expiry date:
14.5.2039
Title in English:
IN VITRO AND XENOGRAFT ANTI-TUMOR ACTIVITY OF A HALOGENATED-XANTHENE AGAINST REFRACTORY PEDIATRIC SOLID TUMORSLanguage of the patent:
English
Timeline
Today
15.5.2019EP application
9.8.2023EP Publication
Owner
Name:
Provectus Pharmatech, Inc.Address:
10025 Investment Drive, Suite 250, Knoxville, Tennessee 37932, US
Name:
The Governors of the University of CalgaryAddress:
2500 University Drive NW, Calgary, Alberta T2N 1N4, CA
Inventor
Name:
SINGER, JamieAddress:
Knoxville, TN 37932, US
Name:
WACHTER, Eric A.Address:
Knoxville, TN 37932, US
Name:
SWIFT, LucyAddress:
Calgary, Alberta T2N 1N4, CA
Name:
ZHANG, ChunfenAddress:
Calgary, AB T2N 1N4, CA
Name:
TRIPPETT, TanyaAddress:
New York, NY 10174, US
Name:
NARENDRAN, AruAddress:
Calgary, AB T2N 1N4, CA
Priority
Number:
201862672373 PDate:
16.5.2018Country:
US
Classification
Categories:
A61K 31/352, A61K 45/06, A61P 35/00, A61K 31/365, A61K 31/4745, A61K 31/475, A61K 31/704, A61K 31/7048, A61K 31/7068, A61K 33/24, A61K 31/343